Skip to content

Innoviva, Inc. INVA Operating Income

Operating Income at other companies

AbbVie logo
AbbVieABBV
$3.99B+6.9%
Insmed logo
InsmedINSM
-$153.32M+38.2%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$117.42M+20.0%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$46.11M+30.9%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$17.37M+148%
Alkermes logo
AlkermesALKS
-$48.28M-450%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s operating income?
Innoviva, Inc. (INVA) reported operating income of $38.15M in Q1 2026.
How has Innoviva, Inc.'s operating income changed year-over-year?
Innoviva, Inc.'s operating income decreased by 7.9% year-over-year, from $41.43M to $38.15M.
What is the long-term trend for Innoviva, Inc.'s operating income?
Over 3 years (2021 to 2025), Innoviva, Inc.'s operating income has grown at a -24.1% compound annual growth rate (CAGR), from $375.1M to $163.75M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.